Neutropenia, a common side effect of chemotherapy for ovarian cancer, was observed in a 47-year-old female patient undergoing a six-cycle chemotherapy regimen. She experienced recurrent neutropenia and leukopenia but refused granulocyte colony-stimulating factor (G-CSF) due to severe bone pain and high costs. Moxibustion combined with guasha therapy (MGT) was administered each time neutropenia occurred. The treatment involved guasha therapy on the bladder meridian (BL) and the governor vessel (GV), followed by moxibustion at Zhongwan (CV 12), Guanyuan (CV 4), and Shenzhu (GV 12) points over 2-3 days. This approach led to the recovery of neutrophil and leukocyte counts, enabling the patient to complete six chemotherapy cycles without G-CSF. These findings suggest that MGT may enhance neutrophil and leukocyte counts in patients with chemotherapy-induced myelosuppression, presenting a potential alternative for those intolerant to G-CSF. However, further high-quality research is needed to confirm its efficacy.

BackgroundProstate cancer (PCa) is the most common non-cutaneous malignancy in men globally. Sappan lignum, which exists in the heartwood of Caesalpinia sappan L., has antitumor effects; however, its exact mechanism of action remains unclear. This study elucidated the underlying mechanisms of Sappan lignum in PCa through network pharmacology approaches and molecular docking techniques. Moreover, the therapeutic effects of Sappan lignum on PCa were verified through in vitro experiments.MethodsThe constituent ingredients of Sappan lignum were retrieved from the HERB database. Active plant-derived compounds of Sappan lignum were screened based on gastrointestinal absorption and gastric drug properties. Disease targets for PCa were screened using unpaired and paired case datasets from the Gene Expression Omnibus. Intersection targets were used for gene ontology and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis. Core targets were identified through topological analysis parameters and their clinical relevance was validated through The Cancer Genome Atlas database. The affinity between the phytochemicals of Sappan lignum and core proteins was verified using the molecular docking technique. Validation experiments confirmed the significant potential of Sappan lignum in treating PCa.ResultsTwenty-one plant-derived compounds of Sappan lignum and 821 differentially expressed genes associated with PCa were collected. Among 32 intersection targets, 8 were screened according to topological parameters. KEGG analysis indicated that the antitumor effects of Sappan lignum on PCa were primarily associated with the p53 pathway. The molecular docking technique demonstrated a strong affinity between 3-deoxysappanchalcone (3-DSC) and core proteins, particularly cyclin B1 (CCNB1). CCNB1 expression correlated with clinicopathological features in patients with PCa. Experimental results revealed that 3-DSC exhibited anti-proliferative, anti-migratory, and pro-apoptotic effects on 22RV1 and DU145 cells while also causing G2/M phase cell cycle arrest, potentially through modulating the p53/p21/CDC2/CCNB1 pathway.ConclusionThis research highlights the promising therapeutic potential of Sappan lignum in treating PCa, with a particular focus on targeting the p53 pathway.

Objectives This meta-analysis aimed to systematically evaluate the efficacy of acupuncture in treating postsurgical gastroparesis syndrome (PGS) after thoracic or abdominal surgery. Design Systematic review and meta-analysis. Data sources Twelve databases (PubMed, Embase, Cochrane Library Cochrane Central Register of Controlled Trials (CENTRAL), Medline (Ovid) (from 1946), Web of Science, EBSCO, Scopus, Open Grey, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chinese Scientific Journals Database (VIP) and China Biology Medicine disc (CBM)) and three registration websites (WHO International Clinical Trials Registry Platform (ICTRP), ClinicalTrials.gov, and Chinese Clinical Trial Registry (ChiCTR)) were searched from the inception to September 2022, and citations of the included literature were screened. Eligibility criteria All randomised controlled trials addressing invasive acupuncture for PGS. Data extraction and synthesis Key information on the included studies was extracted by two reviewers independently. Risk ratio (RR) with 95% CI was used for categorical data, and mean difference with 95% CI for continuous data. The quality of evidence was assessed using Grading of Recommendations Assessment, Development and Evaluation. Outcomes were conducted with trial sequential analysis (TSA). Results Fifteen studies with 759 patients met the inclusion criteria. Subgroup analyses revealed that compared with the drug group, the drug and acupuncture group had a greater positive effect on the total effective rate (TER) (nine trials, n=427; RR=1.20; 95% CI 1.08 to 1.32; P-heterogeneity=0.20, I 2 =28%, p=0.0004) and the recovery rate (RCR) (six trials, n = 294; RR = 1.61; 95% CI 1.30 to 1.98; P-heterogeneity=0.29, I 2 =19%, p<0.0001) of PGS after abdominal surgery. However, acupuncture showed no significant advantages in terms of the TER after thoracic surgery (one trial, p=0.13) or thoracic/abdominal surgery-related PGS (two trials, n = 115; RR=1.18; 95% CI 0.89 to 1.57; P-heterogeneity=0.08, I 2 =67%, p=0.24) and the RCR after thoracic/abdominal surgery (two trials, n=115; RR=1.40; 95% CI 0.97 to 2.01; P-heterogeneity=0.96, I 2 =0%, p=0.07). The quality of evidence for TER and RCR was moderate certainty. Only one study reported an acupuncture-related adverse event, in the form of mild local subcutaneous haemorrhage and pain that recovered spontaneously. TSA indicated that outcomes reached a necessary effect size except for clinical symptom score. Conclusion Based on subgroup analysis, compared with the drug treatment, acupuncture combined drug has significant advantages in the treatment of PGS associated with abdominal surgery, but not with thoracic surgery. PROSPERO registration number CRD42022299189.

Objective To investigate the effect of Yinlai Decoction (YD) on the microstructure of colon, and activity of D-lactic acid (DLA) and diamine oxidase (DAO) in serum of pneumonia mice model fed with high-calorie and high-protein diet (HCD). Methods Sixty male Kunming mice were randomly divided into 6 groups by the random number table method: normal control, pneumonia, HCD, HCD with pneumonia (HCD-P), YD (229.2 mg/mL), and dexamethasone (15.63 mg/mL) groups, with 10 in each group. HCD mice were fed with 52% milk solution by gavage. Pneumonia mice was modeled with lipopolysaccharide inhalation and was fed by gavage with either the corresponding therapeutic drugs or saline water, twice daily, for 3 days. After hematoxylin-eosin staining, the changes in the colon structure were observed under light microscopy and transmission electron microscope, respectively. Enzyme-linked immunosorbent assay was used to detect the protein levels of DLA and DAO in the serum of mice. Results The colonic mucosal structure and ultrastructure of mice in the normal control group were clear and intact. The colonic mucosal goblet cells in the pneumonia group tended to increase, and the size of the microvilli varied. In the HCD-P group, the mucosal goblet cells showed a marked increase in size with increased secretory activity. Loose mucosal epithelial connections were also observed, as shown by widened intercellular gaps with short sparse microvilli. These pathological changes of intestinal mucosa were significantly reduced in mouse models with YD treatment, while there was no significant improvement after dexamethasone treatment. The serum DLA level was significantly higher in the pneumonia, HCD, and HCD-P groups as compared with the normal control group ( P <0.05). Serum DLA was significantly lower in the YD group than HCD-P group ( P <0.05). Moreover, serum DLA level significantly increased in the dexamethasone group as compared with the YD group ( P <0.01). There was no statistical significance in the serum level of DAO among groups ( P >0.05). Conclusions YD can protect function of intestinal mucosa by improving the tissue morphology of intestinal mucosa and maintaining integrity of cell connections and microvilli structure, thereby reducing permeability of intestinal mucosa to regulate the serum levels of DLA in mice.

Background. We intended to explore the mechanism of Yinlai decoction in the treatment of lipopolysaccharide (LPS)-induced pneumonia from the perspective of intestinal flora. Methods. Thirty Sprague–Dawley rats were randomly assigned to the blank control group (N), the pneumonia group (P), and the Yinlai decoction group (PT). The rat pneumonia model was established using LPS inhalation (0.5 mg/mL, 5 mL, 30 min/day, 3 days). Yinlai decoction was administered intragastrically (2 mL/100 g, 3 days). Lung tissue pathology, organ indexes, serum inflammatory factors, tumor necrosis factor-alpha (TNF-α), and intestinal flora changes were measured. Results. Lung tissue inflammation was prevented by Yinlai decoction. IL-6 levels showed a higher tendency to be higher, and IL-12 and TNF-α were significantly higher in the PT group than in the P group. The structure of the intestinal flora in the P differed from that in the N. The relative abundance of 10 out of 12 microflora was significantly higher in the P group than in the N and PT groups. In the PT group, the structure and the distribution of microbial groups were like those of the N group. Conclusions. Yinlai decoction inhibited LPS-induced lung and systemic inflammation in rats and may help the intestinal flora restore equilibrium by inhibiting the colonization of pathogenic bacteria and adjusting the ratio between probiotics and pathogenic bacteria. Intestinal flora may serve as a mediator of Yinlai decoction’s effect on LPS-induced pneumonia.

目的 系统评价艾灸治疗恶性肿瘤化疗后引起的白细胞减少症的疗效.方法 通过全面检索中国知网、万方、维普、Pubmed、Wed of Science等数据库中发表的艾灸治疗化疗引起的白细胞减少症临床随机对照试验文献,用Cochorane系统评价方法,依据纳入、排除标准筛选文献、整理资料,采用Rev Man5.4软件进行质量评价和Meta分析.结果 最终纳入18篇.Meta分析显示艾灸治疗化疗后白细胞减少症较常规升白药物疗效好,差异有统计学意义.结论 艾灸治疗化疗后白细胞减少症的疗效较好,操作方便,值得推广.

Background: Hypoxia is widespread in solid tumors and is directly associated with colorectal cancer (CRC) aggressiveness, poor prognosis, and immunotherapy resistance. In this study, we aimed at developing a hypoxia-related marker to improve the prognosis prediction in CRC.Methods: We used gene expression data of CRC samples from the Cancer Genome Atlas Database and the hypoxia gene set to obtain a hypoxia gene expression matrice of 479 CRC patients. The prognostic model was constructed by screening hypoxia risk genes that were significantly associated with prognosis by univariate and multivariate Cox regression analysis. The predictive performance of the prognostic model was evaluated by Kaplan-Meier survival curve analyses and ROC curve analysis and validated in the GSE17536 dataset of Gene Expression Omnibus database. Finally, we analyzed the immune cell infiltration and expression of immunosuppressive genes in CRC patients at high and low risk of hypoxia.Results: We constructed a hypoxia risk prognostic model composed of two hypoxia-related genes ( SLC2A3 and ENO3 ), which was proved to have better sensitivity and specificity after a series of validation. Independent prognostic analysis revealed that the risk score can serve as an independent prognostic factor for CRC. The infiltration of natural killer resting cells, activated master cells and T-cell regulatory cells were significantly increased in the hypoxia high-risk group, and Gene Set Enrichment Analysis showed that gene sets involved in tumor proliferation and differentiation, immune tolerance as well as hypoxia were also significantly enriched in this group. Negatively regulated genes in the Cancer Immunity Cycle, as well as immune checkpoints, were upregulated in the high hypoxia risk group, forming an immunosuppressive microenvironment, and mediating the immune escape. Conclusions: In summary, we constructed and validated a reliable hypoxia risk model that can independently predict the prognosis of CRC patients and reflect the status of the immune microenvironment, which is beneficial for screening CRC prognostic biomarkers and therapeutic targets.

Background: Long non-coding RNAs (lncRNAs) play an important role in the immune processes of glioma. Immune related lncRNAs (IRlncRs) may be a critical prognosis in patients with glioma. The current study aimed to construct a glioma immune-related prognosis model by IRlncRs. Methods: Transcriptome RNA-sequencing data of glioma were obtained from The Cancer Genome Atlas (TCGA) and an immune‑related risk score (IRRS) model was constructed by Lasso and multivariate Cox regression analysis. Receiver Operating Characteristic (ROC) curves were used to assess the sensitivity and specificity of the prognosis on IRRS. A predictive nomogram and a time-dependent ROC curve was performed in training and validation cohort. We explored the relationships between survival‑related IRlncRs (sIRlncRs) and clinicopathologic parameters. Functional annotation of the sIRlncRs was investigated by gene set enrichment analysis (GSEA) and principal component analysis (PCA). The relationships between IRRS model and immune cell infiltration and co-expression network analysis among the sIRlncRs were performed for molecular mechanism study. Results: A total of 10 sIRlncRs were enrolled to build IRRS model. The IRRS was identified as an independent prognostic factor and correlated with the overall survival (AUC =0.880). The nomogram was constructed successfully with IRRS, age and grade as variables. Immune cell infiltration analysis indicated that B cells, neutrophil, dendritic and macrophage cells were positively correlated with IRRS. PCA and GSEA illustrated that the lncRNA signature enrolled the IRRS model was closely related to immune status. Additionally, co-expression network showed that there was a strong correlation between 10 sIRlncRs at the transcriptional level. Conclusion: We successfully constructed a remarkable clinical model of sIRlncRs with potential prognostic value for glioma patients, which provides an insight into immunological research and treatment strategies of glioma.

目的 评价艾灸对放化疗患者淋巴细胞及其亚群影响的临床疗效,为指导临床应用提供证据.方法 在中国知网(CNKI)、中国学术期刊数据库(万方数据库)、中国科技期刊数据库(维普)、中国生物医学文献数据库(SinoMed)、PubMed、Cochrane图书馆等数据库,检索艾灸治疗恶性肿瘤患者的随机对照临床试验(Randomized Controlled Clinical Trails,RCTs),日期截止至2019年12月,由2名单独研究者进行数据提取及循证方法学质量评价,并应用RevMan 5.3软件进行数据分析,二分类变量数据结果采用相对危险度(RR)来分析效应量,连续性变量数据结果则采用平均差(MD)表示,区间估计用95％CI.结果 纳入14篇RCTs,治疗后试验组CD3+、CD4+淋巴细胞计数、NK细胞计数及CD4/CD8+比值较对照组升高,差异有统计学意义,结果分别为(MD=5.27,P＜0.00001,95％ CI[3.76～6.79];MD=3.96,P＜0.00001,95％CI[3.01～4.91];MD=5.74,Z=3.58,P=0.0003,95％ CI[2.60～8.88];MD=3.96,P＜0.00001,95％ CI[3.01～4.91]).CD8+淋巴细胞亚群计数比较,差异无统计学意义(MD=-1.01,P=0.44,95％ CI[-3.59～1.57]).试验组患者KPS评分较对照组升高,差异有统计学意义(MD=9.57,P=0.007,95％CI为[2.61～16.53]).由于纳入文献整体质量偏低,异质性较高,倒漏斗图提示可能存在发表偏倚.结论 艾灸可升高恶性肿瘤患者淋巴细胞及其亚群计数,提高其KPS评分,能够保护机体免疫功能,提高患者生活质量.受纳入研究整体质量影响,尚需设计严谨、报告规范的高质量临床研究进一步证实.

Abstract Background: N6-methyladenosine (m6A) methylation modification can affect the tumorigenesis, progression, and metastasis of breast cancer (BC). Up to now, a prognostic model based on m6A methylation regulators for BC is still lacking. This study aimed to construct an accurate prediction prognosis model by m6A methylation regulators for BC patients.Methods: After processing of The Cancer Genome Atlas (TCGA) datasets, the differential expression and correlation analysis of m6A RNA methylation regulators were applied. Next, tumor samples were clustered into different groups and clinicopathologic features in different clusters were explored. By univariate Cox and Least Absolute Shrinkage and Selection Operator (LASSO) analysis, m6A regulators with prognostic value were identified to develop a prediction model. Furthermore, we constructed and validated a predictive nomogram to predict the prognosis of BC patients.Results: 19 m6A related genes were extracted and 908 BC patients enrolled from TCGA dataset. After univariate Cox and LASSO analysis, 3 m6A RNA methylation regulators (YTHDF3, ZC3H13 and HNRNPC) were selected to establish the prognosis model based on median risk score (RS) in training and validation cohort. With the increasing of RS, the expression levels of YTHDF3 and ZC3H13 were individually elevated, while the HNRNPC expressed decreasingly. By survival analysis and Receiver Operating Characteristic (ROC) curve, we found that the overall survival (OS) of high-risk group was significantly shorter than that of the low-risk group based on Kaplan-Meier (KM) analysis in each cohort. Univariate and multivariate analysis identified the RS, age, and pathological stage are independent prognostic factors. A nomogram was constructed to predict 1- and 3-year OS and the calibration plots validate the performance. The C-index of nomogram reached 0.757 (95% CI:0.7-0.814) in training cohort and 0.749 (95% CI:0.648-0.85) in validation cohort, respectively.Conclusions: We successfully constructed a predictive prognosis model by m6A RNA methylation regulators. These results indicated that the m6A RNA methylation regulators are potential therapeutic targets of BC patients.

肺癌是最常见恶性肿瘤之一,其发病率、死亡率高,且呈上升趋势.咳嗽是其最常见症状之一,也多为首发症状,且肺癌的咳嗽各具特点,临证时黄金昶教授通过抓主证的方法进行辩治,取得较好的临床效果.本文疏理肺癌患者常见的咳嗽类型,总结黄金昶教授治疗肺癌患者咳嗽的临床经验.黄金昶教授指出了肺癌患者临床最常见的九种咳嗽,包括因痒作咳,卧则咳嗽,动则咳剧,饮热呛咳,因痰而咳,剧烈阵咳,咳痰无力,脏结实咳,慢性咳嗽等,并分析相关病因病机,提出相应的治疗方案.黄金昶教授治疗肺癌咳嗽经验独到,疗效显著,值得学习与临床推广.

Background and objective: Cancer is a life-threatening disease worldwide and current standard therapy cannot fulfill all clinical needs. Chinese herbal injections have been widely used for cancer in Chinese and Western hospitals in China. This study aimed to apply evidence mapping in order to provide an overview of the clinical application of Chinese herbal injections in cancer care based on randomized controlled trials, systematic reviews, and meta-analyses.Methods and results: Seven databases were systematically searched for eligible randomized controlled trials, systematic reviews, and meta-analyses for ten Chinese herbal injections used in cancer treatment and covered in the Chinese national essential health insurance program. Excel 2016 and RStudio were used to integrate and process the data.In total 366 randomized controlled trials and 48 systematic reviews and meta-analyses were included in the evidence mapping of herbal medicines including; Compound Kushen, Shenqi Fuzheng, Aidi, Kangai, Kanglaite, Xiaoaiping, Cinobufacin, Brucea javanica oil emulsion, Polyporus polysaccharide injection, and Astragalus polysaccharide for injection. Health insurance restricts the scope of clinical application for these herbal injections. The numbers of studies published increased, especially around 2013–2015. The most studied cancer types were lung cancer (118, 32.2%), colorectal cancer (39, 10.7%), and gastric cancer (39, 10.7%), and the most used injections were Compound Kushen (78, 21.3%), Shenqi Fuzheng (76, 20.8%), and Aidi (63, 17.2%). The most consistently reported benefits were observed for Compound Kushen, Shenqi Fuzheng, Aidi, and Kangai for tumor response, quality of life, myelosuppression, and enhancing immunity.Conclusion: The current evidence mapping provides an overview of the outcomes and effects of Chinese herbal injections used in cancer care, and offers information on their clinical application which warrants further evidence-based research in order to inform clinical and policy decision-making.

目的 研制儿童胃肠积热评价性量表.方法 由专业人员采集了453例研究对象的临床信息,共包括38个症状及体征.采用5种方法进行条目筛选,包括基于经典测量理论的离散趋势法、相关系数法、克朗巴赫系数法及因子分析法和项目反应理论.最终保留至少4种方法保留的条目,并结合专业知识形成量表.结果 最终形成量表共有25个条目,包括面赤、唇红、咽红肿、舌红、舌苔黄、手足心热、脉数、脉滑、恶热、口臭、口渴喜冷饮、食欲异常、腹痛、大便次数减少、大便干结、排便费力、大便臭、小便色黄、夜间汗出、夜卧不安、烦躁、鼻衄、鼻痂、易呼吸道感染和饮食不节则加重.其中10个条目为二分类变量,以有或无分级;15个条目为四分类变量,以频率或程度分级.结论 形成了以胃肠积热为核心的评价量表,为胃肠积热与相关疾病的研究奠定了基础.

Acu-moxibustion oncology is an emerging subject which needs further exploration in many aspects. We tried to describe the origin and application of acu-moxibustion oncology in this paper. It is a novel therapy based on the combination of traditional meridian theory, classical traditional Chinese and Western medicine knowledge and new theories and viewpoints on tumors. Acupuncture surrounding tumors can change tumor microenvironment. Surrounding acupuncture alone can inhibit the growth of tumors, if combining with chemotherapy, it increases the tumor targeting of chemotherapy drugs, and may reduce the risk of drug-resistance. Surrounding acupuncture will probably become a breakthrough of tumor inhibition by acu-moxibustion. We hope that this novel therapy of traditional Chinese medicine will play a bigger role in tumors treatment.

目的:探究胃肠积热对肺炎大鼠肺、结肠组织的促炎反应和抗炎反应的影响.方法:SD大鼠40只,随机分为正常组、胃肠积热组、肺炎组、胃肠积热合并肺炎组,Aimplex法检测肺、结肠组织细胞因子表达.结果:胃肠积热组大鼠肺组织促炎因子升高,结肠组织抗炎因子水平降低;胃肠积热合并肺炎组大鼠肺、结肠组织促炎因子水平较胃肠积热组同步降低,肺、结肠组织抗炎因子水平低于正常大鼠.结论:胃肠积热可能通过同时激活肺组织促炎反应和肠组织的抗炎反应,导致机体出现双向免疫失衡状态,在此基础上感染肺炎后,肺部促炎反应向持续低水平炎症逆转,同时肠组织免疫抑制状态持续加重,最终导致肺部感染迁延难愈.

Intestinal flora plays an important role in inflammatory response to systemic or local organs of its host. High calorie diet has been shown to aggravate the condition of pneumonia and delay recovery, especially in children. However, the underlying mechanisms remain unclear. This study placed SPF rats in a conventional environment, high calorie diet or LPS atomization was performed respectively or combined. Analysis of high-throughput sequencing of intestinal content combined with animal weight, organ index, serum inflammatory factors indicators and bioinformatics found that after pulmonary infection combined with a high-calorie diet, rats showed significant changes such as weight loss and increased lung weight index, and their lung and intestinal tissues showed more obvious inflammatory changes. And its gut flora structure suggests, the abundance of Leuconostocaceae in significantly reduced; abundance of Staphylococcus, Planococcaceae, Staphylococcus, Staphylococcaceae, Bacillales, Gemellales and Aerococcus significant increased. The study showed that high calorie diet and LPS atomization synergistically promoted pneumonia process in rat pups, which is related to changes in structure of intestinal flora. It is worth noting that pneumonia rats fed by convention diet also causing intestinal flora imbalance.

目的 基于脑肠轴与免疫、炎症、发热的关系,运用多源数据库信息整合法探讨银莱汤干预脑肠轴相关靶点的作用机制,为实验研究提供靶向性指导.方法 检索中药系统药理学数据库与分析平台(TCMSP)及PubChem、David数据库,构建银莱汤靶标数据库,检索SCI文献以建立脑肠轴靶标数据库,通过对银莱汤靶标和脑肠轴靶标进行对比分析,获得银莱汤干预脑肠轴潜在靶标.结果 发现银莱汤药物化学成分429个,银莱汤的作用靶标689个,脑肠轴相关靶标99个,银莱汤干预脑肠轴的潜在靶标35个.结论 银莱汤干预脑肠轴的靶标主要集中在与脑肠肽相关的酶,主要功能为免疫、炎症、能量代谢,可参与人体的免疫应答、氧化损伤等.

目的 基于网络药理学探讨草果知母汤治疗癫痫的活性成分、作用靶点和作用机制.方法 采用中药系统药理学数据库和分析平台和毒性与基因比较数据库获取活性成分并垂钓靶标,与中医药整合药理学研究平台v1.0的数据进行整合,得到最终的草果知母汤治疗癫痫靶标.采用全球蛋白质资源数据库进行蛋白基因互译,在相互作用基因/蛋白质的检索工具网站进行基因本体生物过程富集分析和信号通路富集分析,构建"中药-活性成分-核心靶标-关键通路"多层次网络图和各靶标间相互作用关系网络图.结果 得到草果知母汤的活性成分75个和草果知母汤治疗癫痫靶标89个,其作用机制涉及钠离子通道蛋白1亚单位 α、钠离子通道蛋白2亚单位 α、钠离子通道蛋白8亚单位 α、RAC-α-丝氨酸/苏氨酸蛋白激酶、γ-氨基丁酸受体亚单位 β-2、γ-氨基丁酸受体亚单位 β-3、γ-氨基丁酸受体亚单位 δ等多个关键靶点以及神经活性配体-受体相互作用、各种神经突触通路、钙信号通路、雌激素信号通路、细胞衰老、药物及烟酒成瘾等多条通路发挥抗癫痫的作用.结论 草果知母汤治疗癫痫的作用机制是多途径、多靶点的.

BACKGROUND:Aberrant DNA methylation patterns are involved in the pathogenesis of papillary renal cell carcinoma (pRCC). This study aimed to investigate the potential of methylation-driven genes as biomarkers in determining the prognosis of pRCC by bioinformatics analysis.METHODS:DNA methylation and transcriptome profiling data were downloaded from The Cancer Genome Atlas database. Methylation-driven genes (MDGs) were obtained using MethylMix R package. A Cox regression model was used to screen for pRCC prognosis-related MDGs, and a linear risk model based on MDG methylation profiles was constructed. A combined methylation and gene expression survival analysis was performed to further explore the prognostic value of MDGs independently.RESULTS:A total of 31 MDGs were obtained. Univariate and multivariate Cox regression analysis identified eight genes (CASP1, CD68, HOXD3, HHLA2, HOXD9, HOXA10-AS, TMEM71, and PLA2G16), which were used to construct a predictive model associated with overall survival in pRCC patients. Combined DNA methylation and gene expression survival analysis revealed that C19orf33, GGT6, GIPC2, HHLA2, HOXD3, HSD17B14, PLA2G16, and TMEM71 were significantly associated with patients' survival.CONCLUSION:Through the analysis of MDGs in pRCC, this study identified potential biomarkers for precision treatment and prognosis prediction, and provided the basis for future research into the molecular mechanism of pRCC.

目的:挖掘谷晓红教授治疗小儿急性上呼吸道感染的组方用药规律,分析组方可能存在的药物靶标及相互作用,探索核心药物的作用机制.方法:收集谷晓红教授医案数据库中小儿急性上呼吸道感染的医案,采用中医传承辅助平台软件分析药物间的关联规则,挖掘核心药物及新方组合;运用SPSS软件对药物的性味归经进行系统聚类分析;运用TCMSP、String及KEGG数据库分析新方组合各药物靶标间相互作用关系及相关通路.结果:在筛选出的164首处方中,挖掘出2个核心药物组合和2首新方组合,总结出性味归经相近的6个高频药群,得到新方组合活性成分195个,相关药物靶标1406个,急性上呼吸道感染靶标31312个,药物-疾病交集靶标1385个,其中核心靶标300个.这些靶标构成的网络中共存在相互作用4430项、相关通路25条(P<0.001),其中与呼吸系统关系最密切的是细胞凋亡、T细胞受体信号通路、MAPK信号通路、Toll样受体信号通路,新方组合核心靶标52个.结论:谷晓红教授治疗小儿急性上呼吸道感染以辛凉透表、和胃化湿法为主,其机制可能是通过调控细胞凋亡,调控炎性反应及免疫应答等多靶标复杂通路的共同干预实现.